Jury says Zometa didn't cause ONJ; start-up targets gag reflex

Dear DrBicuspid Member,

A U.S. federal jury has ruled in favor of Novartis Pharmaceuticals in a lawsuit questioning whether the company's bisphosphonate product, Zometa, led to a patient developing osteonecrosis of the jaw. This is the fourth Zometa case to go to trial, and the second that Novartis has won. Read more in this latest Cosmetics Community feature.

In technology news, a start-up company formed by a group of current and former students from Miami University is commercializing a unique approach to a common problem in dentistry for which there are few effective solutions: the gag reflex. Read more.

And Carestream has introduced a 2D and 3D imaging system with multiple fields-of-view that is designed to bring a broader range of imaging capabilities to the dental office while at the same time reducing radiation exposure. Click here or go to the Imaging & CAD/CAM Community to read more.

Finally, three years ago the American Academy of Pediatric Dentistry made a commitment to its members to help ensure that at-risk children get the dental care they need. Now its charitable foundation, Healthy Smiles, Healthy Children, has announced the latest round of grants to five organizations that provide oral health services to underserved children and those with limited access to care. Read more.